The Week in Review: October 20 – October 27, 2017

Friday, October 27, 2017 News Recap: Patient and Caregiver input is requested by BC Pharmacare on AbbVie’s combo of glecaprevir and pibrentasvir (GP) for Genotypes 1-6. We need to hear your voice by November 8, 2017!  AbbVie’s “GP” combo is pan-genotypic (works for all genotypes). Liver Meeting 2017: I’m A HCV Patient – Show Me What I Need to Know! Why reinvent the wheel? The good folks over at HCV New Drugs have put together this great overview o...

Patient and Caregiver input is requested by BC Pharmacare on AbbVie’s combo of glecaprevir and pibrentasvir (GP) for Genotypes 1-6

URGENT BC Patient and Caregiver Input Request: We need to hear your voice! Patient and Caregiver input is requested by BC Pharmacare on AbbVie’s combo of glecaprevir and pibrentasvir (GP) for Genotypes 1-6.  AbbVie’s “GP” combo is pan-genotypic (works for all genotypes).  Check out the background information in links below to learn the results that have been achieved in clinical trials to date. You will see that the cure rates across all genotypes are hig

The Week in Review: May 12, 2017 – May 19, 2017

Friday, May 19, 2017 News Recap Canada Help4Hep – BC Helpline Now Online: Did you know that there is now a British Columbia toll-free hepatitis C peer-to-peer helpline where you can get accurate information and meaningful help that is free of charge and confidential?  Check it out now! Help4Hep – BC Helpline Now Online URGENT! Patient and Caregiver Input Request: We Need to Hear your Voice! Patient and Caregiver input is requested by CADTH on Abb...

Patient and Caregiver input is requested by CADTH on AbbVie’s combo of glecaprevir and pibrentasvir (G/P)

URGENT!  Patient and Caregiver Input Request: We Need to Hear your Voice! Patient and Caregiver input is requested by CADTH on AbbVie’s BRAND NEW (not yet for sale in Canada!) combo of glecaprevir and pibrentasvir (G/P) for Genotypes 1-6.  AbbVie’s G/P combo is pan-genotypic (works for all genotypes).  Check out the background information in links below to see the results that have been achieved in clinical trials to date. You will see that the cure rates